Search results
Results from the WOW.Com Content Network
Balloon pulmonary angioplasty (BPA) is an emerging minimally invasive procedure to treat chronic thromboembolic pulmonary hypertension (CTEPH) in people who are not suitable for pulmonary thromboendarterectomy (PTE) or still have residual pulmonary hypertension and areas of narrowing in the pulmonary arterial tree following previous PTE. [1] [2]
Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term disease caused by a blockage in the blood vessels that deliver blood from the heart to the lungs (the pulmonary arterial tree). These blockages cause increased resistance to flow in the pulmonary arterial tree which in turn leads to rise in pressure in these arteries ...
The accuracy of pulmonary angiography may be higher than clinical examination, arterial blood gas results, and ventilation/perfusion scan. [2] Pulmonary angiography is also used to confirm chronic thromboembolic pulmonary hypertension (CTEPH) and provides a platform for balloon pulmonary angioplasty to treat the disease. [3]
Angioplasty is used to treat venous stenosis affecting dialysis access, with drug-coated balloon angioplasty proving to have better 6 month and 12 month patency than conventional balloon angioplasty. [13] Angioplasty is occasionally used to treat residual subclavian vein stenosis following decompression surgery for thoracic outlet syndrome. [14]
Embolization refers to the passage and lodging of an embolus within the bloodstream. It may be of natural origin (pathological), in which sense it is also called embolism, for example a pulmonary embolism; or it may be artificially induced (therapeutic), as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor ...
In the past, doctors once thought that tissue moved into the mother’s lungs, causing an embolism or a blockage that impacts normal heart and lung function by blocking circulation.
The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.
Ms Coffey, 53, from Manchester, New Hampshire, was diagnosed with breast cancer in 2013 and later fell ill with complex regional pain syndrome, a potentially debilitating neurological condition.